|
![]() |
|
|
Penicillin G
drug data and news
Penicillin G drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.
|
| Generic name | Penicillin G | ||
| Brand Names/Synonyms | Abbocillin; Ayercillin; Benzopenicillin; Benzylpenicillin; Benzylpenicillin G; Benzylpenicillinic Acid; Bicillin; Bicillin L-A; Cillora; Cilloral; Cilopen; Compocillin G; Cosmopen; Crysticillin 300 A.S.; Dropcillin; Duracillin A.S.; Free Benzylpenicillin; Free Penicillin G; Free Penicillin Ii; Galofak; Gelacillin; Liquacillin; Megacillin; Pencillin G; Penicillin; Penicillin G; Penicillin G Potassium; Penicillin G Potassium in Plastic Container; Penicillin G Procaine; Penicillin G Sodium; Penicillin-G Potassium; Penicillinic Acid, Benzyl-; Pentids; Pentids '200'; Permapen; Pfizerpen; Pfizerpen G; Pfizerpen-As; Pharmacillin; Phenylacetamidopenicillanic Acid; Pradupen; Specilline G; Ursopen; Wycillin | ||
| Indication | Infections (penicillin sensitive when extended) | ||
| Sponsored links | Description | Not Available | |
| Pharmacology | Penicillin G is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Penicillin G has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Penicillin G results from the inhibition of cell wall synthesis and is mediated through Penicillin G binding to penicillin binding proteins (PBPs). Penicillin G is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. | ||
| Mechanism Of Action | By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Penicillin G inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Penicillin G interferes with an autolysin inhibitor. | ||
| Penicillin G News (When available) |
First comprehensive HIV/STI management guidelines now available May 4, 2006 | ||
| Dosage Forms | SUSPENSION | ||
| Drug_Category | Anti-bacterial Agents; Penicillins; ATC:J01CE01 | ||
| Absorption | Not Available | ||
| Interactions |
Drug Interactions for Penicillin G: Concurrent administration of bacteriostatic antibiotics (e.g., erythromycin, tetracycline) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth. Bactericidal agents work most effectively against the immature cell wall of rapidly proliferating microorganisms. This has been demonstrated in vitro; however, the clinical significance of this interaction is not well documented. There are few clinical situations in which the concurrent use of ''static'' and ''cidal '' antibiotics are indicated. However, in selected circumstances in which such therapy is appropriate, using adequate doses of antibacterial agents and beginning penicillin therapy first, should minimize the potential for interaction. Penicillin blood levels may be prolonged by concurrent administration of probenecid which blocks the renal tubular secretion of penicillins. Displacement of penicillin from plasma protein binding sites will elevate the level of free penicillin in the serum. | ||
| Toxicity | Not Available | ||
| Organisms Affected | Enteric bacteria and other eubacteria | ||
| Chemical IUPAC Name | 3,3-dimethyl-6-oxo-7-(2-phenylacetyl)amino-2-thia-5-azabicyclo[3.2.0]heptane-4-carboxylicacid | ||
| Chemical Formula | C16H18N2O4S | ||
| Molecular Weight | 334.391 g/mol | ||
| Smiles String | CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C | ||
| Melting Point | Not Available | ||
| Water Solubility | Not Available | ||
| State | Solid | ||
| LogP/Hphobicity | Not Available | ||
| Isoelectric Point | Not Available | ||
| Biotransformation | Not Available | ||
| Half Life | Not Available | ||
| Protein Binding [%] | Not Available | ||
| RxList Link | RXlist | ||
| Sponsored links | |||
| Drug Reference |
http://www.drugs.com/cons/Penicillin_G.html http://www.rxlist.com/cgi/generic3/pengk.htm | ||
| Drug Type | Approved Drug | ||
| Accession No | APRD00646 | ||
| CAS Registry Number | 61-33-6 | ||
| KEGG Compound ID | C05551 | ||
| PubChem ID | SID:7885 | ||
| PharmGKB ID | PA450842 | ||
| SwissProt ID | Not Available | ||
| GenBank ID | Not Available | ||
| Drug ID Number [DIN] | 712981 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |